Biocorp Production Future Growth
Future criteria checks 5/6
Biocorp Production is forecast to grow earnings and revenue by 136.3% and 47.9% per annum respectively while EPS is expected to grow by 136.8% per annum.
Key information
136.3%
Earnings growth rate
136.8%
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | 47.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Oct 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 45 | 18 | 10 | N/A | 1 |
12/31/2024 | 24 | 1 | 0 | N/A | 1 |
12/31/2023 | 19 | 0 | -2 | N/A | 1 |
6/30/2023 | 13 | -2 | N/A | N/A | N/A |
3/31/2023 | 12 | -1 | N/A | N/A | N/A |
12/31/2022 | 12 | -1 | -1 | 0 | N/A |
9/30/2022 | 11 | -1 | -1 | 0 | N/A |
6/30/2022 | 10 | -1 | -1 | 1 | N/A |
3/31/2022 | 10 | 0 | -1 | 0 | N/A |
12/31/2021 | 10 | 0 | -1 | 0 | N/A |
9/30/2021 | 9 | -1 | -3 | -1 | N/A |
6/30/2021 | 8 | -2 | -4 | -2 | N/A |
3/31/2021 | 8 | -1 | -3 | -1 | N/A |
12/31/2020 | 8 | -1 | -3 | 0 | N/A |
9/30/2020 | 8 | -1 | -1 | 1 | N/A |
6/30/2020 | 7 | -1 | 1 | 3 | N/A |
3/31/2020 | 8 | 0 | 1 | 2 | N/A |
12/31/2019 | 8 | 1 | 1 | 2 | N/A |
9/30/2019 | 8 | 0 | -2 | -1 | N/A |
6/30/2019 | 7 | -1 | -5 | -4 | N/A |
3/31/2019 | 6 | -3 | -5 | -5 | N/A |
12/31/2018 | 4 | -5 | -6 | -5 | N/A |
9/30/2018 | 4 | -6 | -5 | -4 | N/A |
6/30/2018 | 3 | -8 | -4 | -4 | N/A |
3/31/2018 | 3 | -8 | -5 | -4 | N/A |
12/31/2017 | 2 | -8 | -5 | -4 | N/A |
9/30/2017 | 2 | -6 | -5 | -4 | N/A |
6/30/2017 | 2 | -5 | -5 | -4 | N/A |
3/31/2017 | 3 | -5 | N/A | -4 | N/A |
12/31/2016 | 3 | -4 | N/A | -3 | N/A |
9/30/2016 | 3 | -4 | N/A | -3 | N/A |
6/30/2016 | 3 | -4 | N/A | -3 | N/A |
3/31/2016 | 3 | -2 | N/A | -3 | N/A |
12/31/2015 | 3 | -1 | N/A | -3 | N/A |
12/31/2014 | 2 | 0 | N/A | -1 | N/A |
12/31/2013 | 2 | 0 | N/A | N/A | N/A |
12/31/2012 | 2 | N/A | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8BP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).
Earnings vs Market: 8BP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8BP is expected to become profitable in the next 3 years.
Revenue vs Market: 8BP's revenue (47.9% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 8BP's revenue (47.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 8BP's Return on Equity is forecast to be high in 3 years time